Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Plu-Bureau

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Annales D'Endocrinologie|April 6, 1999
[Hereditary risks of breast cancer. Interaction of genetic factors and hormonal factors]G Plu-Bureau, J C Thalabard
Contraception, Fertilite, Sexualite (1992)|April 1, 1997
[Oral contraception and the risk of breast cancer]G Plu-Bureau, M G Lê
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 10, 2009
[Therapeutic management of menometrorrhagia in hemostasis disorders]G Plu-Bureau, M-H Horellou
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 14, 2002
Progestins and cancerR Sitruk-Ware, G Plu-Bureau
La Revue De Medecine Interne|December 6, 2014
[Venous thromboembolism and pregnancy]M-H Horellou, G Plu-Bureau, J Lepercq
Computer Methods and Programs in Biomedicine|March 1, 1989
A program running under MS-DOS for the analysis of epidemiologic stratified or matched dataJ C Thalabard, G Plu-Bureau, B Falissard
Revue D'Epidemiologie Et De Sante Publique|July 13, 2000
[Oral contraception and genetic factors in breast cancer: characteristics and limits of case-only studies]G Plu-Bureau, N Bossard, J C Thalabard
Gynecologie, Obstetrique, Fertilite & Senologie|November 4, 2018
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines]G Plu-Bureau, E Sabbagh, J Hugon-Rodin
Gynecologie, Obstetrique, Fertilite & Senologie|March 24, 2021
[Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]J Hugon-Rodin, S Perol, G Plu-Bureau
Gynecologie, Obstetrique, Fertilite & Senologie|April 12, 2021
[Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]L Maitrot-Mantelet, S Perol, G Plu-Bureau
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Annales D'Endocrinologie|April 6, 1999
[Hereditary risks of breast cancer. Interaction of genetic factors and hormonal factors]G Plu-Bureau, J C Thalabard
Contraception, Fertilite, Sexualite (1992)|April 1, 1997
[Oral contraception and the risk of breast cancer]G Plu-Bureau, M G Lê
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 10, 2009
[Therapeutic management of menometrorrhagia in hemostasis disorders]G Plu-Bureau, M-H Horellou
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 14, 2002
Progestins and cancerR Sitruk-Ware, G Plu-Bureau
La Revue De Medecine Interne|December 6, 2014
[Venous thromboembolism and pregnancy]M-H Horellou, G Plu-Bureau, J Lepercq
Computer Methods and Programs in Biomedicine|March 1, 1989
A program running under MS-DOS for the analysis of epidemiologic stratified or matched dataJ C Thalabard, G Plu-Bureau, B Falissard
Revue D'Epidemiologie Et De Sante Publique|July 13, 2000
[Oral contraception and genetic factors in breast cancer: characteristics and limits of case-only studies]G Plu-Bureau, N Bossard, J C Thalabard
Gynecologie, Obstetrique, Fertilite & Senologie|November 4, 2018
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines]G Plu-Bureau, E Sabbagh, J Hugon-Rodin
Gynecologie, Obstetrique, Fertilite & Senologie|March 24, 2021
[Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]J Hugon-Rodin, S Perol, G Plu-Bureau
Gynecologie, Obstetrique, Fertilite & Senologie|April 12, 2021
[Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]L Maitrot-Mantelet, S Perol, G Plu-Bureau
Pageof 7